Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.05). Revenue for the quarter came in at $8.5 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement